View source for Diabetology Ltd

{{Infobox_Company|
  company_name   = Diabetology Ltd|
  company_logo   = |
  company_type   = [[Privately held company|Private]]|
  company_slogan = |
  foundation     = November [[2002]]|
  location       = {{flagicon|Jersey}} [[Saint Helier]], [[Jersey]]|
  key_people     = [[Roger New]] ([[Chief scientific officer|CSO]])<br/>[[Glen Travers]]|
  num_employees  = |
  industry       = [[Biotechnology]]|
  products       = 2 in clinical development and 1 in pre-clinical development|
  homepage       = [http://www.diabetology.co.uk/ www.diabetology.co.uk]|
  revenue        = |
  net_income     = |
}}

'''Diabetology Ldt''' is a [[biopharmaceutical]] company based in [[Saint Helier]], [[Jersey]].

It was founded in November [[2002]] and is developing oral drugs for the treatment of [[diabetes mellitus]].

==Products==
Currently the company doesn't have a marketed product, though its pipeline includes one drug that has recently completed phase II clinical development, one in phase II clinical development, and one in pre-clinical development<ref>http://www.diabetology.co.uk/projects.htm</ref>.

{| border = "1"
| Drug
| Phase
| Action 
|- 
| [[Capsulin OAD]]
| Phase II [[clinical trial]] completed
| Oral [[insulin]] for [[diabetes mellitus type 2]]
|- 
| [[Capsulin IR]]
| Phase II [[clinical trial]]
| Oral [[insulin]] for [[diabetes mellitus type 1]]
|- 
| [[Combulin]]
| [[Pre-clinical development]]
| Oral combination of [[insulin]] and insulin sensitizing agents for [[diabetes mellitus type 2]]
|}

==References==
{{reflist|2}}

==External links==
*[http://www.diabetology.co.uk www.diabetology.co.uk]

{{med-company-stub}}

[[Category:Biotechnology companies]]
[[Category:Economy of Jersey]]